基本信息
浏览量:147
职业迁徙
个人简介
Prof. Dr. Leufkens is research and policy-wise active at several (inter)national platforms on pharmacoepidemiology (e.g. past co-opted member for pharmacoepidemiology of the EMA CHMP 2009-2015, past-President of ISPE), pharmacovigilance (past-member EMA Pharmacovigilance Working Party), orphan drugs (past-Chairman of the Dutch Steering Committee on Orphan Drugs), pharma policy (since 2008 Scientific Director of the Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation), regulatory science and scenario planning. He is (co) author of >450 papers in peer reviewed journals, book chapters and research reports.
研究兴趣
论文共 510 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Bulletin of the World Health Organizationno. 1 (2024): 22-31
Orphanet Journal of Rare Diseasesno. 1 (2024): 1-16
Aleksandra Opalska,Helga Gardarsdottir, Marcel Kwa,Jadwiga Wójkowska‑Mach,Monica Sabate,Maria Elena Ballarin, Mark de Groot,Hubert Leufkens
European journal of clinical pharmacologyno. 10 (2024): 1581-1589
Enrico Costa, Antonella Isgro, Mariane de Montalembert,Hubert G. M. Leufkens,Russell E. Ware,Lucia De Franceschi
BLOOD ADVANCESno. 10 (2024): 2455-2465
Drug discovery todayno. 10 (2023): 103725-103725
加载更多
作者统计
#Papers: 511
#Citation: 12764
H-Index: 56
G-Index: 92
Sociability: 7
Diversity: 4
Activity: 70
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn